Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro 10mg is a mid-range dose within the licensed tirzepatide schedule, and in the UK's private market, prices for a single monthly pen at this strength have typically ranged from around £200 to £375 since Eli Lilly raised its list price in September 2025. That range is real, but it doesn't tell the whole story. Mounjaro is a prescription-only medicine — no one can legally supply it without a clinical assessment by a qualified prescriber. So when you're comparing Mounjaro 10mg price figures across providers, the question worth asking isn't just what the pen costs, but what clinical oversight and support are wrapped around it. At nume, we don't print per-pen prices in this article; current treatment pricing is shown on our treatment page, alongside everything that's included.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
NICE's appraisal of tirzepatide (TA1026) confirmed it as a clinically meaningful treatment for weight management, and the SURMOUNT-1 trial, published in the New England Journal of Medicine, reported average weight reductions of around 20–21% at the 15mg maintenance dose over 72 weeks. The 10mg dose sits two steps below that ceiling on the licensed UK schedule (2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg) meaning many patients reach it after three or four months of treatment, once their system has adjusted.
Eli Lilly's UK list price increase, which came into effect on 1 September 2025, pushed the 15mg pen's list price from roughly £122 to roughly £330. Lower doses tend to sit below that ceiling, but private providers price according to their own cost base and service model, so what you see advertised as Mounjaro prices across the market reflects more than the medicine itself. Understanding that context makes the numbers less confusing. The NHS tirzepatide rollout, covered in detail on the Mounjaro overview page, follows strict eligibility criteria and phased timelines, private treatment exists for people who don't meet those criteria yet, or who'd rather not wait.
A listed figure for a Mounjaro pen rarely covers everything involved in getting the medicine safely and legally. Consultation fees are sometimes charged separately, as are prescription fees, delivery costs and, critically, any ongoing clinical support between doses. Some providers charge for dose-increase reviews or require a separate appointment each time your prescription is renewed. That last point matters at 10mg specifically: titrating upward, or deciding to stay at this dose, is a clinical judgement, not an automatic step. You can explore the full cost breakdown for Mounjaro 10mg if you want a more granular comparison framework.
There's also the question of what happens if something goes wrong. Nausea, reflux and fatigue are among the most commonly reported side effects when a dose increases, the NHS tirzepatide page lists these in plain language. Access to a prescriber when those effects arise isn't always part of a bare-bones plan. Nor is GP notification, which reputable providers carry out in line with GPhC guidance. These aren't luxuries. They're what makes a private weight-loss service clinical rather than transactional.
We are deliberately not the cheapest provider in this market. That's a choice, not an oversight. The single price you pay covers the consultation, the prescription, the medicine, next-working-day DPD delivery and seven-day aftercare, nothing billed separately, no subscription trapping you into auto-renewals. Every repeat order gets a fresh clinical review before it's approved. There are no discount codes, no promotional offers and no vouchers. A prescription medicine sold at a steep discount through an unverified seller is a red flag, not a saving, the MHRA has warned publicly about counterfeit weight-loss pens circulating online, some of which have contained the wrong substance entirely.
If you're weighing up whether the Mounjaro 10mg price at a given provider is reasonable, the question to ask is what's actually included. You can read more about what 'cheap Mounjaro 10mg' listings actually mean in practice, and how much 10mg Mounjaro costs across different service models. For context on what happened to pricing after the September 2025 list price change, the Mounjaro price increase page covers the detail. At nume, a GPhC-registered Independent Prescriber reviews your consultation the same day, you can verify our pharmacy on the GPhC register directly.
Price comparison makes sense for many things. For a prescription-only injectable medicine that requires ongoing clinical oversight, it's the wrong lens. The relevant questions are: is the pharmacy GPhC-registered and verifiable? Is a qualified prescriber reviewing your case personally? Is the medicine sourced through the licensed UK supply chain? Is there clinical support if your side effects are significant, or if your dose needs to change?
Tirzepatide pens stored incorrectly (left outside the fridge for longer than the leaflet allows, for instance) may lose effectiveness before the month is out. The pen sitting in your fridge door at home arrived there through a chain of decisions that started with choosing a regulated service. That chain matters. If you'd like a prescriber to review whether 10mg is the right stage for you, or whether treatment is appropriate at all, our free consultation is the place to start. There's no commitment, no hidden fee for the assessment, and a named clinician reviews it the same day. You can also read more about our weight-loss treatment options if you're still deciding which route suits you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.